Biogen Inc (BIIB-Q) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$2.96	$4.24	$15.76	$15.96
Number of Estimates	28	24	16	15
High Estimate	$4.68	$4.80	$16.33	$17.60
Low Estimate	$1.66	$3.25	$14.49	$13.15
Prior Year	$3.02	$5.47	$15.28	$15.76
Growth Rate Est. (year over year)	-1.99%	-22.49%	+3.14%	+1.27%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$1.99	$4.81	$5.47	$3.02
Estimate	$1.61	$3.89	$3.93	$3.26
Difference	+0.38	+0.92	+1.54	-0.24
Surprise	+23.60%	+23.65%	+39.19%	-7.36%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.85

3 Mths Ago34

3.83

2 Mths Ago35

3.83

1 Mth Ago35

3.97

Current34

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	34	35	35	34
	14 1	14 1	14 1	16 1
Holds	19	20	20	17

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says